| Reference |
|---|
Heitman K, Bollenbecker S, Bradley J, Czaya B, Fajol A, Thomas S, et al. Hyperphosphatemia Contributes to Skeletal Muscle Atrophy in Mice. Int J Mol Sci. 2024;25: pubmed publisher |
Fuchs M, Burke E, Latic N, Murray S, Li H, Sparks M, et al. Fibroblast Growth Factor (FGF) 23 and FGF Receptor 4 promote cardiac metabolic remodeling in chronic kidney disease. Res Sq. 2023;: pubmed publisher |
Courbon G, Kentrup D, Thomas J, Wang X, Tsai H, Spindler J, et al. FGF23 directly inhibits osteoprogenitor differentiation in Dmp1-knockout mice. JCI Insight. 2023;8: pubmed publisher |
Meyer M, Benkusky N, Lee S, Yoon S, MANNSTADT M, Wein M, et al. Rapid genomic changes by mineralotropic hormones and kinase SIK inhibition drive coordinated renal Cyp27b1 and Cyp24a1 expression via CREB modules. J Biol Chem. 2022;298:102559 pubmed publisher |
Czaya B, Heitman K, Campos I, Yanucil C, Kentrup D, Westbrook D, et al. Hyperphosphatemia increases inflammation to exacerbate anemia and skeletal muscle wasting independently of FGF23-FGFR4 signaling. elife. 2022;11: pubmed publisher |
Navarro Garc xed a J, Salguero Bodes R, Gonz xe1 lez Lafuente L, Mart xed n Nunes L, Rodr xed guez S xe1 nchez E, Bada Bosch T, et al. The anti-aging factor Klotho protects against acquired long QT syndrome induced by uremia and promoted by fibroblast growth factor 23. BMC Med. 2022;20:14 pubmed publisher |
Lee T, Chung C, Lee T, Lin Y, Kao Y, Chen Y. Fibroblast Growth Factor 23 Stimulates Cardiac Fibroblast Activity through Phospholipase C-Mediated Calcium Signaling. Int J Mol Sci. 2021;23: pubmed publisher |
Chen W. Soluble Alpha-Klotho Alleviates Cardiac Fibrosis without Altering Cardiomyocytes Renewal. Int J Mol Sci. 2020;21: pubmed publisher |
Westphal S, Gantert T, Kless C, Hüttinger K, Klingenspor M, Fromme T. Fibroblast growth factor 8b induces uncoupling protein 1 expression in epididymal white preadipocytes. Sci Rep. 2019;9:8470 pubmed publisher |
Meyer M, Benkusky N, Kaufmann M, Lee S, Redfield R, Jones G, et al. Targeted genomic deletions identify diverse enhancer functions and generate a kidney-specific, endocrine-deficient Cyp27b1 pseudo-null mouse. J Biol Chem. 2019;294:9518-9535 pubmed publisher |
Zhu L, Stein L, Kim D, Ho K, Yu G, Zhan L, et al. Klotho controls the brain-immune system interface in the choroid plexus. Proc Natl Acad Sci U S A. 2018;115:E11388-E11396 pubmed publisher |
Quarto N, Shailendra S, Meyer N, Menon S, Renda A, Longaker M. Twist1-Haploinsufficiency Selectively Enhances the Osteoskeletal Capacity of Mesoderm-Derived Parietal Bone Through Downregulation of Fgf23. Front Physiol. 2018;9:1426 pubmed publisher |
Kägi L, Bettoni C, Pastor Arroyo E, Schnitzbauer U, Hernando N, Wagner C. Regulation of vitamin D metabolizing enzymes in murine renal and extrarenal tissues by dietary phosphate, FGF23, and 1,25(OH)2D3. PLoS ONE. 2018;13:e0195427 pubmed publisher |
Yashiro M, Ohya M, Mima T, Ueda Y, Nakashima Y, Kawakami K, et al. FGF23 modulates the effects of erythropoietin on gene expression in renal epithelial cells. Int J Nephrol Renovasc Dis. 2018;11:125-136 pubmed publisher |
Agoro R, Montagna A, Goetz R, Aligbe O, Singh G, Coe L, et al. Inhibition of fibroblast growth factor 23 (FGF23) signaling rescues renal anemia. FASEB J. 2018;32:3752-3764 pubmed publisher |
Si W, Zhang Y, Chen K, Hu D, Qian Z, Gong S, et al. Fibroblast growth factor type 1 receptor stimulation of T-type Ca2+ channels in sensory neurons requires the phosphatidylinositol 3-kinase and protein kinase A pathways, independently of Akt. Cell Signal. 2018;45:93-101 pubmed publisher |
Kuroda M, Muramatsu R, Maedera N, Koyama Y, Hamaguchi M, Fujimura H, et al. Peripherally derived FGF21 promotes remyelination in the central nervous system. J Clin Invest. 2017;127:3496-3509 pubmed publisher |
Smith E, Tan S, Holt S, Hewitson T. FGF23 is synthesised locally by renal tubules and activates injury-primed fibroblasts. Sci Rep. 2017;7:3345 pubmed publisher |
Grabner A, Schramm K, Silswal N, Hendrix M, Yanucil C, Czaya B, et al. FGF23/FGFR4-mediated left ventricular hypertrophy is reversible. Sci Rep. 2017;7:1993 pubmed publisher |
Guibert M, Gasser A, Kempf H, Bianchi A. Fibroblast-growth factor 23 promotes terminal differentiation of ATDC5 cells. PLoS ONE. 2017;12:e0174969 pubmed publisher |
Kawakami K, Takeshita A, Furushima K, Miyajima M, Hatamura I, Kuro O M, et al. Persistent fibroblast growth factor 23 signalling in the parathyroid glands for secondary hyperparathyroidism in mice with chronic kidney disease. Sci Rep. 2017;7:40534 pubmed publisher |
Lindberg I, Pang H, Stains J, Clark D, Yang A, Bonewald L, et al. FGF23 is endogenously phosphorylated in bone cells. J Bone Miner Res. 2015;30:449-54 pubmed publisher |
Ohata Y, Yamazaki M, Kawai M, Tsugawa N, Tachikawa K, Koinuma T, et al. Elevated fibroblast growth factor 23 exerts its effects on placenta and regulates vitamin D metabolism in pregnancy of Hyp mice. J Bone Miner Res. 2014;29:1627-38 pubmed publisher |
Andrukhova O, Smorodchenko A, Egerbacher M, Streicher C, Zeitz U, Goetz R, et al. FGF23 promotes renal calcium reabsorption through the TRPV5 channel. EMBO J. 2014;33:229-46 pubmed publisher |
Touchberry C, Green T, Tchikrizov V, Mannix J, Mao T, Carney B, et al. FGF23 is a novel regulator of intracellular calcium and cardiac contractility in addition to cardiac hypertrophy. Am J Physiol Endocrinol Metab. 2013;304:E863-73 pubmed publisher |
Lau W, Leaf E, Hu M, Takeno M, Kuro O M, Moe O, et al. Vitamin D receptor agonists increase klotho and osteopontin while decreasing aortic calcification in mice with chronic kidney disease fed a high phosphate diet. Kidney Int. 2012;82:1261-70 pubmed publisher |
Faul C, Amaral A, Oskouei B, Hu M, Sloan A, Isakova T, et al. FGF23 induces left ventricular hypertrophy. J Clin Invest. 2011;121:4393-408 pubmed publisher |
Galitzer H, Ben Dov I, Silver J, Naveh Many T. Parathyroid cell resistance to fibroblast growth factor 23 in secondary hyperparathyroidism of chronic kidney disease. Kidney Int. 2010;77:211-8 pubmed publisher |
